Teva Recalls Drugs With Probable Carcinogen

Home
Products & Services

ProfitGuard
Group purchasing and wholesaler contract negotiation service with business intelligence tools.

BuyLine
A no-contract online pharmaceutical ordering service with competitive pricing and loyalty rewards points.

TriNet
Third party contracting services with dedicated customer support.

ScriptCard & ScriptCard Plus
Prescription discount card programs, including $4 generics.

EnsurePay
An automated solution for electronic third party claims reconciliation.

Marketing
Advertising, marketing and website services for independent pharmacies.
About
Elements
News
Resources
Contact

Teva Recalls Drugs With Probable Carcinogen

December 7, 2018

Teva Pharmaceuticals has recalled two drugs used to treat high blood pressure due to the presence of a probable human carcinogen, N-nitroso-diethylamine (NDEA).

The recall affects all lots of:

Amlodipine / Valsartan combination tablets
Amlodipine / Valsartan / Hydrochlorothiazide combination tablets

Pharmacies can contact Teva by phone at 888-838-2872, or email at druginfo@tevapharm.com.

View the full list of recalled products in the FDA press release.

Teva Recalls Drugs With Probable Carcinogen

Related

Archive